Advancing a broad portfolio designed to deliver multiple paradigm-shifting therapies for devastating and underserved immune-mediated diseases – – Lead program afimetoran, a potential best-in-disease ...

Immune system overreactions may be the true culprit of cardiac illness—and lifesaving drugs can calm them down ...

Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic ...

Chronic inflammatory diseases have traditionally been investigated as distinct clinical entities. However, growing evidence indicates that many of these ...

The effect of tumor necrosis factor–alpha inhibitor exposure on skin cancer risk among patients with inflammatory diseases was examined.

A nationwide Italian study finds that patients with immune-mediated inflammatory diseases initially have increased risk for malignancy.

April 13 (Reuters) - Spyre Therapeutics said on Monday its experimental drug demonstrated a significant reduction in disease activity in a mid-stage study of patients with ulcerative colitis. The drug ...

When patients start getting treated for conditions like psoriatic arthritis, or connective tissue diseases like lupus and systemic sclerosis, their heightened risk of cancer gradually decreases, ...

The human immune system is finely tuned to detect and destroy viral threats. But this same defense system can misfire. When ...

By Siddhi Mahatole April 13 (Reuters) - Spyre Therapeutics said on Monday its experimental drug showed a significant ...